Search research articles
Contact Us
Filters
Showing results (31-40 of 91) with videos related to
Page
of 10
Sort By:
The Journal of Invasive Cardiology
|
July 23, 2025
Prognostic implications over time of platelet FcɣRIIa expression in patients with myocardial infarction: a secondary analysis
David J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions
|
March 26, 2025
Predictive Value of Platelet FcγRIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial Infarction
David J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology
|
September 18, 2010
Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study
Dominick J Angiolillo, Jorge F Saucedo, Roger Deraad, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 18, 2014
In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study
Akshay Bagai, Eric D Peterson, Emily Honeycutt, et al.
Circulation
|
July 8, 2026
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association
Robert J DiDomenico, Joel C Marrs, Adam P Bress, et al.
Circulation
|
February 11, 2009
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors
Peter Collins, Lori Mosca, Mary Jane Geiger, et al.
Circulation
|
December 19, 2015
Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study
Connie N Hess, Tracy Y Wang, Lisa A McCoy, et al.
Journal of Cardiovascular Pharmacology
|
January 27, 2011
The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data
Baojin Zhu, Mark B Effron, M Pandurang Kulkarni, et al.
Thrombosis and Haemostasis
|
December 11, 2012
Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study
Jorge F Saucedo, Dominick J Angiolillo, Roger DeRaad, et al.
American Heart Journal
|
September 21, 2015
Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States
Tracy Y Wang, Timothy D Henry, Lisa A McCoy, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 91) with videos related to
Sort By:
Page
of 10
The Journal of Invasive Cardiology
|
July 23, 2025
Prognostic implications over time of platelet FcɣRIIa expression in patients with myocardial infarction: a secondary analysis
David J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions
|
March 26, 2025
Predictive Value of Platelet FcγRIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial Infarction
David J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology
|
September 18, 2010
Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study
Dominick J Angiolillo, Jorge F Saucedo, Roger Deraad, et al.
European Heart Journal. Acute Cardiovascular Care
|
December 18, 2014
In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study
Akshay Bagai, Eric D Peterson, Emily Honeycutt, et al.
Circulation
|
July 8, 2026
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association
Robert J DiDomenico, Joel C Marrs, Adam P Bress, et al.
Circulation
|
February 11, 2009
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors
Peter Collins, Lori Mosca, Mary Jane Geiger, et al.
Circulation
|
December 19, 2015
Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study
Connie N Hess, Tracy Y Wang, Lisa A McCoy, et al.
Journal of Cardiovascular Pharmacology
|
January 27, 2011
The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data
Baojin Zhu, Mark B Effron, M Pandurang Kulkarni, et al.
Thrombosis and Haemostasis
|
December 11, 2012
Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study
Jorge F Saucedo, Dominick J Angiolillo, Roger DeRaad, et al.
American Heart Journal
|
September 21, 2015
Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States
Tracy Y Wang, Timothy D Henry, Lisa A McCoy, et al.
Page
of 10